|
市場調査レポート
欧州のジェネリック医薬品およびバイオシミラー市場における価格および償還動向
Pricing and Reimbursement Issues for Generics & Biosimilars Markets in Europe
|
Abstract
This Frost & Sullivan research service titled Pricing and Reimbursement Issues
for Generics & Biosimilars Markets in Europe provides a detailed analysis of
various issues affecting pricing and reimbursement decisions of generics in
Europe. The study includes an overview of cost-containment measures such as
reference pricing, parallel trade, generic substitution, patient co-payments
and reimbursement. Certain key issues such as the EU accession, the
Roche/Bolar provision, data exclusivity and marketing authorisation
applications are also discussed.
Table of Contents
1. Executive Summary
2. Glossary of Terms
3. Research Methodology
- 1. Methodology Of Research
- 1. The "12 Step" Market Engineering Research Methodology and Process
4. Introduction
- 1. Overview
- 1. Market Analysis
- 2. Scope and Objectives
- 3. Pricing and Reimbursement
- 4. The Biosimilars Opportunity
5. Key Trends
- 1. Pharmaceutical Cost-containment Measures
- 1. Reference Pricing
- 2. Parallel Trade
- 3. Generic Substitution
- 4. Patient Co-payments and Reimbursement
- 2. Political/Legal/Regulatory Issues
- 1. Impact of EU Accession
- 2. The Roche/Bolar Provision
- 3. Data Exclusivity and Marketing Authorisation Applications
6. Country-wise Policy Analysis
- 1. Group I
- 1. Denmark
- 2. Germany
- 3. The Netherlands
- 4. The United Kingdom
- 2. Group II
- 1. Austria
- 2. Belgium
- 3. France
- 4. Italy
- 5. Portugal
- 6. Spain
- 3. Group III
- 1. Central and Eastern Europe (CEE)
7. Market Participants
- 1. Market Players
- 1. List of Generics Market Participants
- 2. List of Biosimilars Market Participants
8. Strategic Recommendations
- 1. Recommendations to Market Participants
9. Decision Support Databases
- 1. DSDs
- 1. Total Healthcare Expenditure
- 2. Pharma R&D Expenditure
List of Figures
Chapter 4
- Generics Market: Market Share of Generics by Value and Volume (Europe),
2004
Chapter 5
- Generics Market: Country-wise Policy on Generic Substitution (Europe), 2006
- Generics Market: Average Time Required for Pricing and Reimbursement
Approvals (Europe), 2004
Chapter 7
- Generics Market: List of Key Market Participants (Europe), 2006
- Biosimilars Market: List of Key Market Participants (Europe), 2006
|
